Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (21-30 of 287) with videos related to

Pageof 29
Sort By:
The Canadian Journal of Urology|April 30, 2014
Practical guide to the use of abiraterone in castration resistant prostate cancerElahe A Mostaghel, Daniel W Lin
The New England Journal of Medicine|September 1, 2006
Microarray analysis and tumor classificationDaniel W Lin, Peter S Nelson
Clinical Prostate Cancer|March 26, 2004
The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinomaDaniel W Lin, Peter S Nelson
Current Urology Reports|April 18, 2009
New and novel markers for prostate cancer detectionMichael C Risk, Daniel W Lin
Urologic Oncology|March 28, 2015
Measures of survival benefit in cancer drug development and their limitationsRuth Etzioni, Roman Gulati, Daniel W Lin
Cancer|May 26, 2009
Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort StudyDaniel W Lin, Michael Porter, Bruce Montgomery
Urologic Oncology|July 28, 2021
A 25-year perspective on evaluation and understanding of biomarkers in urologic cancersAdam S Feldman, Vinata Lokeshwar, Daniel W Lin
JAMA|March 10, 2025
Prostate Cancer: A ReviewRuben Raychaudhuri, Daniel W Lin, R Bruce Montgomery
JAAPA : Official Journal of the American Academy of Physician Assistants|August 19, 2004
The increasing role of CAM in prostate cancerGabrielle Zecha, Daniel W Lin, R Bruce Montgomery
The Journal of Urology|February 11, 2003
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomyDaniel W Lin, Harry W Herr, Guido Dalbagni
Pageof 29

Showing results (21-30 of 287) with videos related to

Sort By:
Pageof 29
The Canadian Journal of Urology|April 30, 2014
Practical guide to the use of abiraterone in castration resistant prostate cancerElahe A Mostaghel, Daniel W Lin
The New England Journal of Medicine|September 1, 2006
Microarray analysis and tumor classificationDaniel W Lin, Peter S Nelson
Clinical Prostate Cancer|March 26, 2004
The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinomaDaniel W Lin, Peter S Nelson
Current Urology Reports|April 18, 2009
New and novel markers for prostate cancer detectionMichael C Risk, Daniel W Lin
Urologic Oncology|March 28, 2015
Measures of survival benefit in cancer drug development and their limitationsRuth Etzioni, Roman Gulati, Daniel W Lin
Cancer|May 26, 2009
Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort StudyDaniel W Lin, Michael Porter, Bruce Montgomery
Urologic Oncology|July 28, 2021
A 25-year perspective on evaluation and understanding of biomarkers in urologic cancersAdam S Feldman, Vinata Lokeshwar, Daniel W Lin
JAMA|March 10, 2025
Prostate Cancer: A ReviewRuben Raychaudhuri, Daniel W Lin, R Bruce Montgomery
JAAPA : Official Journal of the American Academy of Physician Assistants|August 19, 2004
The increasing role of CAM in prostate cancerGabrielle Zecha, Daniel W Lin, R Bruce Montgomery
The Journal of Urology|February 11, 2003
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomyDaniel W Lin, Harry W Herr, Guido Dalbagni
Pageof 29